BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15999354)

  • 1. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
    J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer.
    Makino T; Yamasaki M; Miyata H; Yoshioka S; Takiguchi S; Fujiwara Y; Nakajima K; Nishida T; Mori M; Doki Y
    Ann Surg Oncol; 2010 Mar; 17(3):804-11. PubMed ID: 19885698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
    Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma.
    He LR; Liu MZ; Li BK; Rao HL; Deng HX; Guan XY; Zeng YX; Xie D
    Cancer Sci; 2009 Sep; 100(9):1591-6. PubMed ID: 19552757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma.
    Gotoh M; Takiuchi H; Kawabe S; Ohta S; Kii T; Kuwakado S; Katsu K
    Jpn J Clin Oncol; 2007 Sep; 37(9):652-7. PubMed ID: 17940077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in radiosensitivity using small interfering RNA targeting p53R2 in esophageal squamous cell carcinoma.
    Yokomakura N; Natsugoe S; Okumura H; Ikeda R; Uchikado Y; Mataki Y; Takatori H; Matsumoto M; Owaki T; Ishigami S; Aikou T
    Oncol Rep; 2007 Sep; 18(3):561-7. PubMed ID: 17671702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF; Perrier H; Monges G; Giovannini M; Gouvernet J
    Gastroenterol Clin Biol; 1995 May; 19(5):465-74. PubMed ID: 7589997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
    Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
    J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
    Shimoyama S; Konishi T; Kawahara M; Aoki F; Harada N; Shimizu S; Murakami T; Kaminishi M
    Hepatogastroenterology; 1998; 45(23):1497-504. PubMed ID: 9840093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma.
    Takatori H; Natsugoe S; Okumura H; Matsumoto M; Ishigami S; Owaki T; Aikou T
    Oncol Rep; 2005 Apr; 13(4):697-701. PubMed ID: 15756444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
    Yamasaki M; Miyata H; Fujiwara Y; Takiguchi S; Nakajima K; Nishida T; Yasuda T; Matsuyama J; Mori M; Doki Y
    Ann Surg Oncol; 2010 Feb; 17(2):634-42. PubMed ID: 19941080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
    Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
    Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy.
    Hironaka S; Hasebe T; Kamijo T; Ohtsu A; Boku N; Yoshida S; Saitoh H; Ochiai A
    Clin Cancer Res; 2002 Jan; 8(1):124-30. PubMed ID: 11801548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula.
    Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma.
    Samejima R; Kitajima Y; Yunotani S; Miyazaki K
    Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
    Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
    Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of apoptosis in oesophageal carcinoma preoperatively treated by chemotherapy and radiotherapy.
    Moreira LF; Naomoto Y; Hamada M; Kamikawa Y; Orita K
    Anticancer Res; 1995; 15(2):639-44. PubMed ID: 7539243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.